Author: Maripuu, M.; Bendix, M.; Öhlund, L.; Widerström, M.; Werneke, U.
Title: Death associated with coronavirus (COVID-19) infection in individuals with severe mental disorders in Sweden during the early months of the outbreak - a exploratory cross-sectional analysis of a population-based register study Cord-id: 2vdgvf5h Document date: 2020_9_18
ID: 2vdgvf5h
Snippet: Background: Individuals with severe mental disorder (SMD) have a higher risk of somatic comorbidity and mortality than the rest of the population. We set up a population-based study to assess whether individuals with SMD had a higher risk of death associated with a COVID-19 infection (COVID-19 associated death) than individuals without SMD. Methods: Exploratory analysis with a cross-sectional design in the framework of a population-based register study covering the entire Swedish population. The
Document: Background: Individuals with severe mental disorder (SMD) have a higher risk of somatic comorbidity and mortality than the rest of the population. We set up a population-based study to assess whether individuals with SMD had a higher risk of death associated with a COVID-19 infection (COVID-19 associated death) than individuals without SMD. Methods: Exploratory analysis with a cross-sectional design in the framework of a population-based register study covering the entire Swedish population. The Swedish Board for Health and Welfare (Socialstyrelsen) provided anonymised tabulated summary data for further analysis. We compared numbers of COVID-19 associated death in individuals with SMD (cases) and without SMD (controls). We calculated the odds ratio (OR) for the whole sample and by age group and four potential risk factors, namely diabetes, cardiovascular disease, hypertension, chronic lung disease. Results: The sample comprised of 7,923,859 individuals, 103,999 with SMD and 7,819,860 controls. There were 130 (0.1%) COVID-19 associated deaths in the SMD group and 4945 (0.06%) in the control group, corresponding to an OR of 1.98 (CI 1.66-2.35; p < 0.001). The odds were fourfold in the age group between 60 and 79 years. Cardiovascular diseases increased the odds by 50%. Individuals with SMD without any of the risk factors under study had three-folds odds of COVID-19 associated death. Conclusion: Our preliminary results suggest that individuals with SMD are a further group at increased risk of COVID-19 associated death. The factors contributing to this increased mortality risk require clarification.
Search related documents:
Co phrase search for related documents- acute organ dysfunction and liver disease: 1
- acute organ dysfunction and lopinavir azithromycin hydroxychloroquine: 1
- acute organ dysfunction and lung disease: 1, 2, 3, 4
- additional condition and liver disease: 1
- liver disease and longitudinal population: 1, 2
- liver disease and lopinavir azithromycin hydroxychloroquine: 1, 2
- liver disease and lopinavir azithromycin hydroxychloroquine chloroquine: 1
- liver disease and lopinavir azithromycin hydroxychloroquine chloroquine infection: 1
- liver disease and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- longitudinal population and lung disease: 1
- lopinavir azithromycin hydroxychloroquine and lung disease: 1
Co phrase search for related documents, hyperlinks ordered by date